These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 25567046

  • 1. Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut.
    Santos AF, Du Toit G, Douiri A, Radulovic S, Stephens A, Turcanu V, Lack G.
    J Allergy Clin Immunol; 2015 Jan; 135(1):179-86. PubMed ID: 25567046
    [Abstract] [Full Text] [Related]

  • 2. Development of a tool predicting severity of allergic reaction during peanut challenge.
    Chinthrajah RS, Purington N, Andorf S, Rosa JS, Mukai K, Hamilton R, Smith BM, Gupta R, Galli SJ, Desai M, Nadeau KC.
    Ann Allergy Asthma Immunol; 2018 Jul; 121(1):69-76.e2. PubMed ID: 29709643
    [Abstract] [Full Text] [Related]

  • 3. Biomarkers of severity and threshold of allergic reactions during oral peanut challenges.
    Santos AF, Du Toit G, O'Rourke C, Becares N, Couto-Francisco N, Radulovic S, Khaleva E, Basting M, Harris KM, Larson D, Sayre P, Plaut M, Roberts G, Bahnson HT, Lack G.
    J Allergy Clin Immunol; 2020 Aug; 146(2):344-355. PubMed ID: 32311390
    [Abstract] [Full Text] [Related]

  • 4. Individually dosed omalizumab: an effective treatment for severe peanut allergy.
    Brandström J, Vetander M, Lilja G, Johansson SG, Sundqvist AC, Kalm F, Nilsson C, Nopp A.
    Clin Exp Allergy; 2017 Apr; 47(4):540-550. PubMed ID: 27883239
    [Abstract] [Full Text] [Related]

  • 5. Predicting reactivity threshold in children with anaphylaxis to peanut.
    Reier-Nilsen T, Michelsen MM, Lødrup Carlsen KC, Carlsen KH, Mowinckel P, Nygaard UC, Namork E, Borres MP, Håland G.
    Clin Exp Allergy; 2018 Apr; 48(4):415-423. PubMed ID: 29284183
    [Abstract] [Full Text] [Related]

  • 6. The relevance of basophil allergen sensitivity testing to distinguish between severe and mild peanut-allergic children.
    Homšak M, Silar M, Berce V, Tomazin M, Skerbinjek-Kavalar M, Celesnik N, Košnik M, Korošec P.
    Int Arch Allergy Immunol; 2013 Apr; 162(4):310-7. PubMed ID: 24193167
    [Abstract] [Full Text] [Related]

  • 7. Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy.
    Blumchen K, Beder A, Beschorner J, Ahrens F, Gruebl A, Hamelmann E, Hansen G, Heinzmann A, Nemat K, Niggemann B, Wahn U, Beyer K.
    J Allergy Clin Immunol; 2014 Aug; 134(2):390-8. PubMed ID: 24831438
    [Abstract] [Full Text] [Related]

  • 8. Basophil activation tests for the diagnosis of food allergy in children.
    Ocmant A, Mulier S, Hanssens L, Goldman M, Casimir G, Mascart F, Schandené L.
    Clin Exp Allergy; 2009 Aug; 39(8):1234-45. PubMed ID: 19549026
    [Abstract] [Full Text] [Related]

  • 9. Basophil allergen threshold sensitivity, CD-sens, IgE-sensitization and DBPCFC in peanut-sensitized children.
    Glaumann S, Nopp A, Johansson SG, Rudengren M, Borres MP, Nilsson C.
    Allergy; 2012 Feb; 67(2):242-7. PubMed ID: 22126416
    [Abstract] [Full Text] [Related]

  • 10. Peanut Allergen Threshold Study (PATS): Novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy.
    Hourihane JO, Allen KJ, Shreffler WG, Dunngalvin G, Nordlee JA, Zurzolo GA, Dunngalvin A, Gurrin LC, Baumert JL, Taylor SL.
    J Allergy Clin Immunol; 2017 May; 139(5):1583-1590. PubMed ID: 28238744
    [Abstract] [Full Text] [Related]

  • 11. Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children.
    Santos AF, Douiri A, Bécares N, Wu SY, Stephens A, Radulovic S, Chan SM, Fox AT, Du Toit G, Turcanu V, Lack G.
    J Allergy Clin Immunol; 2014 Sep; 134(3):645-52. PubMed ID: 25065721
    [Abstract] [Full Text] [Related]

  • 12. Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children.
    Thyagarajan A, Jones SM, Calatroni A, Pons L, Kulis M, Woo CS, Kamalakannan M, Vickery BP, Scurlock AM, Wesley Burks A, Shreffler WG.
    Clin Exp Allergy; 2012 Aug; 42(8):1197-205. PubMed ID: 22805467
    [Abstract] [Full Text] [Related]

  • 13. Oral peanut challenge identifies an allergy but the peanut allergen threshold sensitivity is not reproducible.
    Glaumann S, Nopp A, Johansson SG, Borres MP, Nilsson C.
    PLoS One; 2013 Aug; 8(1):e53465. PubMed ID: 23326435
    [Abstract] [Full Text] [Related]

  • 14. Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.
    Patil SU, Steinbrecher J, Calatroni A, Smith N, Ma A, Ruiter B, Virkud Y, Schneider M, Shreffler WG.
    J Allergy Clin Immunol; 2019 Nov; 144(5):1310-1319.e4. PubMed ID: 31377342
    [Abstract] [Full Text] [Related]

  • 15. Sustained successful peanut oral immunotherapy associated with low basophil activation and peanut-specific IgE.
    Tsai M, Mukai K, Chinthrajah RS, Nadeau KC, Galli SJ.
    J Allergy Clin Immunol; 2020 Mar; 145(3):885-896.e6. PubMed ID: 31805311
    [Abstract] [Full Text] [Related]

  • 16. Basophil Activation Test Utility as a Diagnostic Tool in LTP Allergy.
    Cañas JA, Pérez-Sánchez N, Lopera-Doblas L, Palomares F, Molina A, Bartra J, Torres MJ, Gómez F, Mayorga C.
    Int J Mol Sci; 2022 Apr 29; 23(9):. PubMed ID: 35563370
    [Abstract] [Full Text] [Related]

  • 17. Basophil allergen threshold sensitivity: a useful approach to anti-IgE treatment efficacy evaluation.
    Nopp A, Johansson SG, Ankerst J, Bylin G, Cardell LO, Grönneberg R, Irander K, Palmqvist M, Oman H.
    Allergy; 2006 Mar 29; 61(3):298-302. PubMed ID: 16436137
    [Abstract] [Full Text] [Related]

  • 18. Peanut diversity and specific activity are the dominant IgE characteristics for effector cell activation in children.
    Hemmings O, Niazi U, Kwok M, James LK, Lack G, Santos AF.
    J Allergy Clin Immunol; 2021 Aug 29; 148(2):495-505.e14. PubMed ID: 33675817
    [Abstract] [Full Text] [Related]

  • 19. A comparative study on basophil activation test, histamine release assay, and passive sensitization histamine release assay in the diagnosis of peanut allergy.
    Larsen LF, Juel-Berg N, Hansen KS, Clare Mills EN, van Ree R, Poulsen LK, Jensen BM.
    Allergy; 2018 Jan 29; 73(1):137-144. PubMed ID: 28686296
    [Abstract] [Full Text] [Related]

  • 20. Basophil CD63 assay to peanut allergens accurately diagnoses peanut allergy in patient with negative skin prick test and very low specific IgE.
    Marrs T, Brough HA, Kwok M, Lack G, Santos AF.
    Pediatr Allergy Immunol; 2022 Feb 29; 33(2):e13739. PubMed ID: 35212037
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.